Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2005
10/05/2005EP1581171A2 Antibodies against gpr64 and uses thereof
10/05/2005EP1581169A2 Compositions and methods for the treatment of natural killer cell related diseases
10/05/2005EP1581164A2 Compositions and methods for inhibiting tumor growth and metastasis
10/05/2005EP1581119A2 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
10/05/2005EP1581092A2 Compounds and methods for treatment and diagnosis of chlamydial infection
10/05/2005EP1507851B1 Method for assembling sub units into capsoides
10/05/2005EP1412373A4 Alteration of oil traits in plants
10/05/2005EP1175437B1 Vaccine
10/05/2005EP1123389B1 A method of affinity separation and ligands for use therein
10/05/2005EP0862455A4 Interferon-polymer conjugates and process for preparing the same
10/05/2005EP0775212B1 Control of plant gene expression
10/05/2005CN1678745A The rice restorer gene to the rice BT type cytoplasmic male sterility
10/05/2005CN1678636A Thrombus-resolving and anticoagulation double function fusion protein and use thereof
10/05/2005CN1678635A Specific antibodies proBNP(1-108) for diagnosing heart failure
10/05/2005CN1678632A A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish
10/05/2005CN1678631A Osteoinductive biomaterials
10/05/2005CN1678630A HCV fusion proteins with modified NS3 domains
10/05/2005CN1678629A Peptides
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
10/05/2005CN1678624A Benzoate- and anthranilate-inducible promoters
10/05/2005CN1678346A Vaccine for respiratory and reproductive system infections in cattle
10/05/2005CN1678345A Multi plasmid system for the production of influenza virus
10/05/2005CN1678336A Treatment of disease by inducing cell apoptosis
10/05/2005CN1676610A Novel penicillium marneffei PPIase II, its coding sequence and use
10/05/2005CN1676609A Novel penicillium marnffei PPIase II, its coding sequence and use
10/05/2005CN1676608A Novel penicillium marneffei ERG1 gene, its coding protein and use
10/05/2005CN1676606A Method for reconstructing target protein from protein segment in plant
10/05/2005CN1676530A Matrimony vine arabinogalactan protein, and its preparing process, use and composition
10/05/2005CN1221662C Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
10/05/2005CN1221570C Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
10/05/2005CN1221569C Cell surface molecule mediating cell adhesion and signal transmission
10/05/2005CN1221568C Composition and methods for detecting and treating acquired immunodeficiency syndrome
10/05/2005CN1221567C Technological process of producing recombinant human tissue type plasminogen activator TNK mutant
10/05/2005CN1221566C gClq receptor jointed HIV-lgp120 relative peptide and coded oligonucleotide thereof
10/05/2005CN1221565C Peptides and their derivatives thereof showing cell attachment, spreading and detachment activity
10/04/2005US6952650 Modulators of ribosomal function and identification thereof
10/04/2005US6951970 Regenerating fertility in plants; obtain cells, transform nucleus of a plant cell with fertility vector, detect and recover transformed plants, propagate transformed plants
10/04/2005US6951939 Multivalent platform molecules comprising high molecular weight polyethylene oxide
10/04/2005US6951928 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)
10/04/2005US6951927 Proteins with integrin-like activity
10/04/2005US6951926 Antibody to bladder cancer nuclear matrix protein and its use
10/04/2005US6951924 Antibodies against secreted protein HTEBYII
10/04/2005US6951923 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
10/04/2005US6951922 Antibodies immunologically reactive with broad-spectrum delta endotoxins
10/04/2005US6951921 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins; extracellular
10/04/2005US6951920 PRO1340 polypeptides
10/04/2005US6951919 which functions as an antagonist or apoptosis-inducing activity regulator; tumor necrosis factors; membrane proteins; reduced sensitivity to proteases/metalloproteases
10/04/2005US6951918 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
10/04/2005US6951917 major histocompatability complex (MHC-class II); human leukocyte antigen; recognized by CD4 lymphocytes; immunogens; vaccines; immunotherapy
10/04/2005US6951916 Melanocortin receptor ligands
10/04/2005US6951845 Method for treating allergic lung disease
10/04/2005US6951839 Methods and compositions for regulating lymphocyte activity
10/04/2005US6951758 Helper virus-free AAV production
10/04/2005US6951755 Vectors and methods for gene transfer
10/04/2005US6951754 Expression vector for use as transformation and gene expression tool in genetic engineering
10/04/2005US6951742 Polyclonal and monoclonal antibodies to antigens in poultry or birds, formed using polynucleotide vaccines; proteomics
10/04/2005US6951740 Comprises expression vector for transfection and expression of thrombopoietin in cell; bioreactors and heterologous polypeptide expression
10/04/2005US6951739 Calcium channel modulators; animal husbandry; fish breeding
10/04/2005US6951738 Human tumor necrosis factor receptors TR13 and TR14
10/04/2005US6951737 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/04/2005US6951736 Nucleotide sequences coding polypeptide for use in sex determination in poultry
10/04/2005US6951735 Death domain containing receptors
10/04/2005US6951734 Generate protein for X-ray crystallographic analysis; obtain cell extract, incubate with protein synthesis mixture and label, detect signal from preferential protein
10/04/2005US6951732 Virulence genes, proteins, and their use
10/04/2005US6951724 Nucleotide sequences for use in the detection and diagnosis of brain disorders
10/04/2005US6951721 Monitoring gene expression in cells; obtain cells, isolate genomic nucleotide sequences, determine genotype, determine the frequency of the genotype in cell pool, evaluate pattern of frequency
10/04/2005US6951717 Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
10/04/2005US6951649 Methods of making neuraminidase-supplemented compositions
10/04/2005US6951648 Variant of LAV viruses
10/04/2005US6951647 T cell binding ligand peptides and method of inducing a cellular immune response
10/04/2005US6951646 recognizing conformation dependent epitopes of HCV glycoprotein E2 that are capable of neutralizing the binding of E2 protein onto susceptible cells
10/04/2005CA2105304C Inhibitors of human neutrophil elastase and human cathepsin g
10/04/2005CA2094397C Homobifunctional agents for coupling enzymes and the like to antibodies and the like
09/2005
09/30/2005CA2499791A1 Angptl4/fiaf as marker for ppardelta modulation
09/29/2005WO2005091385A1 Semiconductor light-emitting device and illuminating device
09/29/2005WO2005090995A2 Method for the detection of autoantibodies against specific peptides and its use in diagnosis and treatment of pregnancy-loss or infertility
09/29/2005WO2005090989A1 Agent and method for examining infection with adult taeniasis solium and taeniarhynchus saginatus
09/29/2005WO2005090968A1 Tat-based immunomodulatory compositions and methods of their discovery and use
09/29/2005WO2005090966A2 Diagnostics and therapeutics for diseases associated with peroxisome proliferator activated receptor delta (ppard)
09/29/2005WO2005090602A2 Method for diagnosing or predicting susceptibility to optic nueropathy
09/29/2005WO2005090589A2 Process for the production of l-amino acids using coryneform bacteria
09/29/2005WO2005090579A1 Modified bouganin proteins, cytotoxins and methods and uses thereof
09/29/2005WO2005090576A1 Dna construct for preventing pertussis infection
09/29/2005WO2005090575A1 Glycosylation variants of ricin-like proteins
09/29/2005WO2005090574A1 Vascular endothelial growth inhibiting gene
09/29/2005WO2005090573A2 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
09/29/2005WO2005090569A1 Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof
09/29/2005WO2005090564A1 Gene promoting vascular endothelial cell growth
09/29/2005WO2005090557A1 Method of proliferating pluripotent stem cell
09/29/2005WO2005090402A1 Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing same
09/29/2005WO2005090401A1 Molecules
09/29/2005WO2005090400A1 Immunosuppressive cytokine
09/29/2005WO2005090399A1 Antibody recognizing the proliferation/differentiation of various types of cells and method of evaluating proliferation/differentiation by using the antibody
09/29/2005WO2005090398A1 Genes and polypeptides relating to prostate cancers
09/29/2005WO2005090397A1 Hypha-specific cell wall proteins of candida
09/29/2005WO2005090396A1 Novel mannose-specific adhesins and their use
09/29/2005WO2005090395A2 Methods for increasing protein polyethylene glycol (peg) conjugation
09/29/2005WO2005090394A2 Cyanide tolerant nitrilhydratases
09/29/2005WO2005090393A2 Multimeric protein toxins to target cells having multiple identifying characteristics
09/29/2005WO2005090392A1 Tat-based tolerogen compositions and methods of making and using same
1 ... 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 ... 2916